TNFRSF10A and cancer: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is selectively toxic to various cancer cells, including TNBC cells, by engaging death receptor 4 (DR4) and DR5 while sparing normal cells[4].